While positioned at the forefront of the small modular reactor (SMR) revolution, NuScale Power remains a pre-revenue manufacturer with significant hurdles to clear before it can deliver on its potential as a growth—and eventual dividend—story for investors.
After a significant rebound, ACADIA Pharmaceuticals (ACAD) shares present a conundrum for investors. While a discounted cash flow model suggests deep undervaluation, the stock's volatile history and mixed performance metrics demand a closer look at the underlying narrative.
Over 247,000 residential customers of Potomac Edison, a FirstEnergy subsidiary in Maryland, will see automatic credits on their utility bills this month. The move, part of a state-mandated relief program, underscores the delicate balance utilities must strike between regulatory compliance, infrastructure investment, and consumer affordability pressures.
Bio-Techne (TECH) gains market attention with the launch of its Cultrex Synthetic Hydrogel, a key innovation for 3D cell research. While the product debut coincides with recent share price strength, longer-term returns tell a more complex story for investors.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
SanDisk stock surged over 15% as analysts point to the company's dominant position in supplying high-performance storage for the rapidly expanding AI infrastructure, leading to a dramatic rise in profits and a significantly upgraded price target.
A federal judge has indefinitely blocked the Trump administration's plan to end Temporary Protected Status for Haitians, delivering a reprieve to hundreds of thousands of immigrants and sharply criticizing the decision as 'arbitrary' and potentially racially motivated.
India's latest budget outlines a massive strategic pivot, channeling over $10 billion into domestic rare earths processing and clean energy. The move aims to secure critical mineral supply chains and boost nuclear power, reducing reliance on foreign sources, particularly China.
Personal finance expert Dave Ramsey joins critics in dismissing the concept of a 50-year home loan, arguing it offers minimal monthly savings while drastically increasing long-term costs and risks for homeowners.
A detailed analysis of Alcon Inc. (ALC) highlights the company's market leadership, margin expansion potential, and the upcoming catalyst of its UNITY surgical system, presenting a compelling bull case for the eye care specialist.
With interest rate cuts on the horizon, America's largest homebuilder, D.R. Horton, is positioned to capitalize on pent-up demand from millennials and a potential housing market recovery, presenting a compelling value case for patient investors.
Argan, Inc., a specialized engineering and construction firm, is drawing investor attention with its robust financial performance, zero-debt balance sheet, and strategic positioning in the evolving energy sector. Despite a premium valuation, its record backlog and cash-generating prowess present a compelling bull case.
ResMed Inc., the sleep therapy giant, faces a pivotal moment. While benefiting from a competitor's recall and a growing market funnel, emerging oral treatments and shifting dynamics pose fresh challenges to its long-held CPAP business model.
As the AI infrastructure race intensifies, a critical bottleneck is emerging: memory. With demand for high-bandwidth memory (HBM) skyrocketing, Micron Technology finds itself at the center of a new investment thesis, drawing comparisons to the early days of Nvidia's AI-driven ascent.
A North Carolina mother, mourning the loss of her daughter and the young woman's boyfriend in a head-on collision, speaks out against what she perceives as a culture of irresponsibility glorified in award shows and a justice system that failed to prevent a preventable tragedy.
Despite a recent stock dip, Brookfield Asset Management (BAM) is drawing investor attention for its aggressive growth strategy and operational moat. We analyze the bull case, weighing its fee-earnings trajectory against a premium valuation and macroeconomic headwinds.
As Becton Dickinson's complex Reverse Morris Trust transaction nears its 2026 close, analysts argue the market is overlooking a significant value catalyst and an attractively priced remaining business.
The abrupt Chapter 7 filing of Synergy World Inc., a key gift card partner for Costco, has exposed vulnerabilities in the popular discount gift card market, leaving thousands of cardholders with potentially worthless credits and highlighting broader consumer protection gaps.
Shares of Malaysian bottled water leader Spritzer Bhd have jumped nearly 10% in a month, outpacing the broader market. Analysts point to the company's robust return on equity and consistent profit reinvestment as key drivers behind investor confidence and its impressive earnings growth trajectory.
Despite a historic drop in coal-fired electricity generation, China saw a surge in proposed new and reactivated coal power projects last year, highlighting a strategic push for energy security even as renewables rapidly expand.
